⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30776105 | 1.00 | — | — | |
| SCHEMBL16534475 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL4754646 | 0.97 | — | — | |
| SCHEMBL28823536 | 0.78 | — | — | |
| SCHEMBL709036 | 0.73 | — | — | |
| SCHEMBL711711 | 0.69 | — | — | |
| SCHEMBL22534285 | 0.62 | — | — | |
| SCHEMBL4110340 | 0.56 | — | — | |
| SCHEMBL234916 | 0.55 | — | — | |
| SCHEMBL1449793 | 0.53 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 816 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260035389-A1 | TETRAHYDROPYRIDOPYRIMIDINE PAN-KRAS INHIBITORS | MIRATI THERAPEUTICS INC (US) | 2026-02-05 | — | — | US | claimed |
| US-20260015350-A1 | AZAQUINAZOLINE PAN-KRAS INHIBITORS | MIRATI THERAPEUTICS INC (US) | 2026-01-15 | — | — | US | claimed |
| US-20250368649-A1 | TETRAHYDROPYRIDOPYRIMIDINE PAN-KRAS INHIBITORS | MIRATI THERAPEUTICS INC (US) | 2025-12-04 | — | — | US | claimed |
| US-12398154-B2 | Azaquinazoline pan-KRas inhibitors | Mirati Therapeutics, Inc. (US) | 2025-08-26 | — | — | US | claimed |
| US-20250158123-A1 | NONAQUEOUS ELECTROLYTE FOR NONAQUEOUS-ELECTROLYTE CELL, AND NONAQUEOUS-ELECTROLYTE CELL | PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) | 2025-05-15 | — | — | US | claimed |
| EP-4540254-A1 | TETRAHYDROPYRIDOPYRIMIDINE PAN-KRAS INHIBITORS | Mirati Therapeutics, Inc. (US) | 2025-04-23 | — | — | EP | claimed |
| EP-4540255-A1 | AZAQUINAZOLINE PAN-KRAS INHIBITORS | Mirati Therapeutics, Inc. (US) | 2025-04-23 | — | — | EP | claimed |
| CN-119677749-A | Azaquinazoline pan KRAS inhibitors | 米拉蒂治疗股份有限公司 | 2025-03-21 | — | — | CN | claimed |
| WO-2025002179-A1 | HETEROTRICYCLIC N-[1-(2-BENZOFURANYL)-METHYL]-UREA DERIVATIVES AS PI3K ALPHA INHIBITORS FOR THE TREATMENT OF CANCER | LAEKNA PHARMACEUTICAL NINGBO CO., LTD. (CN) | 2025-01-02 | — | — | WO | claimed |
| EP-4475256-A1 | NONAQUEOUS ELECTROLYTE FOR NONAQUEOUS-ELECTROLYTE CELL, AND NONAQUEOUS-ELECTROLYTE CELL | Panasonic Intellectual Property Management Co., Ltd. (JP) | 2024-12-11 | — | — | EP | claimed |
| US-20130143730-A1 | METAL-LIGAND CATALYST FORMATION | INVISTA NORTH AMERICA S.A.R.L. (US) | 2013-06-06 | — | — | US | claimed |
| WO-2012170300-A2 | IMPROVEMENT IN METAL-LIGAND CATALYST FORMATION | INVISTA TECHNOLOGIES S.A R.L. (CH) | 2012-12-13 | — | — | WO | claimed |
| US-20120296270-A1 | VISCOUS FORMULATIONS AND THEIR USE IN NEEDLE-FREE INJECTION | ZOGENIX, INC. | 2012-11-22 | — | — | US | claimed |
| EP-0945416-B1 | Process for the preparation of 2,4-dichloro-3,5-dimethylfluorobenzene | BAYER AG (DE) | 2002-06-12 | — | — | EP | claimed |
| US-6150571-A | Process for the preparation of 2,4-dichloro-3,5-dimethyl-fluorobenzene | BAYER AKTIENGESELLSCHAFT (DE) | 2000-11-21 | — | — | US | claimed |
| WO-1999011612-A2 | SUBSTITUTED CYCLIC COMPOUNDS AND MIXTURES COMPRISING SAME | ISIS PHARMACEUTICALS, INC. (US) | 1999-03-11 | — | — | WO | claimed |
| US-5684217-A | Process for preparing 3-fluoro-4,6-dichlorotoluene | BAYER AKTIENGESELLSCHAFT (DE) | 1997-11-04 | — | — | US | claimed |
| EP-0292824-B1 | PROCESS FOR THE NUCLEAR CHLORINATION OF AROMATIC HYDROCARBONS | BAYER AG (DE) | 1990-08-01 | — | — | EP | claimed |
| US-4851596-A | Process for nucleus-chlorination of aromatic hydrocarbons | BAYER AKTIENGESELLSCHAFT (DE) | 1989-07-25 | — | — | US | claimed |
| EP-0154904-B1 | ACYLAMINO OXO OR HYDROXY SUBSTITUTED ALKYLAMINO THIAZINES AND THIAZEPINES | E.R. Squibb & Sons, Inc. (US) | 1987-10-28 | — | — | EP | claimed |